Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015-2020.

Blood Cancer J · 2022 · PMC9666639 · PMID 36379917

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The number of studies that stratified treatment based on MRD showed an increasing trend (0 in 2015 to 3 in 2020).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.